Gene expression-based screening for inhibitors of PDGFR signaling.
Alena A Antipova, Brent R Stockwell, Todd R Golub
Index: Genome Biol. 9 , R47, (2008)
Full Text: HTML
Abstract
Here we describe a proof-of-concept experiment designed to explore the possibility of using gene expression-based high-throughput screening (GE-HTS) to find inhibitors of a signaling cascade, using platelet derived growth factor receptor (PDGFR) signaling as the example. The previously unrecognized ability of aurintricarboxylic acid to inhibit PDGFR signaling, discovered through a screen of 1,739 compounds, demonstrates the feasibility and generalizability of GE-HTS for the discovery of small molecule modulators of any signaling pathway of interest.
Related Compounds
Related Articles:
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
2011-01-27
[J. Med. Chem. 54 , 591-602, (2011)]
2011-01-01
[J. Chromatogr. A. 1218(23) , 3689-94, (2011)]
2008-10-15
[Bioorg. Med. Chem. 16 , 9101-5, (2008)]
Generalized Method for the Production of 1, 3-Benzoxazine, 1, 3-Benzothiazine, and Quinazoline Derivatives from 2-(Hydroxy, Thio, or Amino) Aromatic Acids Using Triphenylphosphine Thiocyanogen. Pritchard KM, et al.
[Synth. Commun. 35(!2) , 1601-11, (2005)]
Synthesis of (R)-, (S)-, and (RS)-hydroxymethylmexiletine, one of the major metabolites of mexiletine. Cavalluzzi MM, et al.
[Tetrahedron Asymmetry 18(20) , 2409-17, (2007)]